Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSIP1 | O75475 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA3 | P07451 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA6 | P23280 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.40 |
| ▸ | HTR6 | P50406 | 3/20 | 0.38 |
| ▸ | LOXL2 | Q9Y4K0 | 3/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 6/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | HTR2A | P28223 | 2/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19561677 | 0.76 | PSIP1 (0.56) | PSIP1CA12CA1CA2CA3 | |
| SCHEMBL20388830 | 0.74 | PSIP1 (0.42) | PSIP1CA12CA1CA2CA3 | |
| SCHEMBL21186465 | 0.74 | PSIP1 (0.42) | PSIP1CA12CA1CA2CA3 | |
| SCHEMBL21656681 | 0.74 | PSIP1 (0.42) | PSIP1CA12CA1CA2CA3 | |
| SCHEMBL27845106 | 0.72 | CA12 (0.43) | PSIP1CA12CA1CA2CA3 | |
| SCHEMBL20393067 | 0.72 | KIF11 (0.37) | PSIP1CA12CA6CA7CA9 | |
| SCHEMBL13990531 | 0.72 | CA1 (0.44) | PSIP1CA1CA2CA5ACA9 | |
| SCHEMBL21186462 | 0.72 | PSIP1 (0.46) | PSIP1HTR6SMN1; SMN2TDP1 | |
| SCHEMBL21186486 | 0.70 | PSIP1 (0.39) | PSIP1HTR6TAAR1ALDH1A1TDP1 | |
| SCHEMBL21186463 | 0.70 | PSIP1 (0.39) | PSIP1HTR6TAAR1SMN1; SMN2CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170210765-A1 | PROCESS FOR PREPARING ALPHA-SILYLAMINE COMPOUNDS FROM ALPHA-SILYLMETHYL AZIDE COMPOUNDS | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2017-07-27 | — | — | US | disclosed |
| CN-102385192-B | The manufacture method of cholesteric lcd display, cholesteric lcd display and aligning agent for liquid crystal | JSR CO., LTD. (JP) | 2016-02-10 | — | — | CN | disclosed |
| CN-102337140-B | Liquid crystal aligning agent for retardation film, liquid crystal alignment film for retardation film, and retardation film and process for production thereof | JSR CORP | 2015-04-01 | — | — | CN | disclosed |
| CN-102385192-A | Cholesteric liquid crystal display manufacturing method, cholesteric liquid crystal display and liquid crystal aligning agent | JSR CORP | 2012-03-21 | — | — | CN | disclosed |
| CN-102337140-A | Liquid crystal aligning agent for retardation film, liquid crystal alignment film for retardation film, and retardation film and process for production thereof | JSR CORP | 2012-02-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170210765-A1 | PROCESS FOR PREPARING ALPHA-SILYLAMINE COMPOUNDS FROM ALPHA-SILYLMETHYL AZIDE COMPOUNDS | ITGAL, MANBA, ITGA1 | PSIP1 2757/4885CA12 2711/4885CA1 1301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.